Why the study?
Do Drug-Coated Balloons improve TLPP at 12 months compared to standard PTA in patients with dysfunctional arteriovenous dialysis fistulae?
Do Drug-Coated Balloons improve TLPP at 12 months compared to standard PTA in patients with dysfunctional arteriovenous dialysis fistulae?
Drug-coated balloons demonstrate sustained and superior effectiveness compared to standard PTA for treating dysfunctional arteriovenous dialysis fistulae at 12 months.
Supports DCB preference over PTA for dysfunctional AV fistulae; confirms sustained TLPP benefit in this RCT.
TLPP was statistically significantly higher with DCBs than with standard PTA at 12 months, demonstrating the sustained and superior effectiveness of this device for the treatment of dysfunctional arteriovenous dialysis fistulae.
No takes yet. Share an insight, caveat, or question.
Holden et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: